Clinical Trial Update: The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833) [Phase 3]

View source ↗

Summary

Phase 3 trial P03833 evaluating PegIntron (peginterferon alfa-2b) plus Rebetol (ribavirin) in chronic hepatitis C patients who did not respond to Pegasys; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: TERMINATED | Results posted: 2009-08-04